Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

203.86
Delayed Data
As of Nov 12
 +1.96 / +0.97%
Today’s Change
151.80
Today|||52-Week Range
204.84
+23.02%
Year-to-Date
Here's Why Solid Biosciences Collapsed Today
Nov 12 / MotleyFool.com - Paid Partner Content
Why the Opioid Crisis Makes Vertex Pharmaceuticals a Buy
Nov 06 / MotleyFool.com - Paid Partner Content
2 Beaten-Down Biotech Stocks That Could Make You Rich
Nov 11 / MotleyFool.com - Paid Partner Content
Vertex Pharmaceuticals Inc (VRTX) Q3 2019 Earnings Call Transcript
Oct 31 / MotleyFool.com - Paid Partner Content
3 Top Stocks to Buy in November
Nov 10 / MotleyFool.com - Paid Partner Content
2 Top Healthcare Stocks Every Investor Should Own
Oct 31 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close201.90
Today’s open202.14
Day’s range201.84 - 204.84
Volume939,805
Average volume (3 months)1,232,021
Market cap$51.7B
Data as of 4:00pm ET, 11/12/2019

Growth & Valuation

Earnings growth (last year)+677.36%
Earnings growth (this year)+17.37%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+22.51%
P/E ratio24.7
Price/Sales14.09
Price/Book11.57

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.17+0.15%
----
AGNAllergan+0.38+0.21%
TAKTakeda Pharmaceutica...-0.11-0.56%
Data as of 6:30pm ET, 11/12/2019

Financials

Next reporting dateJanuary 29, 2020
EPS forecast (this quarter)$1.17
Annual revenue (last year)$3.0B
Annual profit (last year)$2.1B
Net profit margin68.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boston, Massachusetts

Forecasts